CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Valencia, Spain and 76 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Valencia, Spain and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Valencia, Valenciana, Comunitat, Spain and 75 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Valencia, Spain and 168 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209...
Phase 1, Phase 2
Valencia, Spain and 50 other locations
to be tested in a larger group of participants and assess preliminary clinical activity of GEN1047. GEN1047 will be studied in a broad group of cancer...
Phase 1, Phase 2
Madrid, Spain and 35 other locations
consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, biliary tract cancer, cervical cancer, endometrial...
Phase 2
Valencia, Spain and 76 other locations
(MORAb-202) in participants with selected tumor types (ovarian cancer [OC], endometrial cancer [EC], non-small cell lung c...
Phase 1, Phase 2
Valencia, Spain and 52 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Valencia, Spain and 125 other locations
This study is designed to investigate the safety and tolerability of a new drug, AZD5363, in patients with advanced cancer - and to identify...
Phase 1
Valencia, Spain and 33 other locations
Clinical trials
Research sites
Resources
Legal